Role of Radiomics to Predict Disease Recurrence in Sinonasal Squamous Cell Carcinoma: A Systematic Review and Meta‐Analysis
Clinical Otolaryngology · 2026-01 · 51 (1) · 7-16
DOI: 10.1111/coa.70031 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical Otolaryngology, online erschienen am 05.09.2025. Verfasst von Caitlin Waters und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Galway University Hospital, Galway, Ireland. Hauptthemen laut MEDLINE: Neoplasm Recurrence, Local, Paranasal Sinus Neoplasms, Carcinoma, Squamous Cell, Magnetic Resonance Imaging. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Radiomics offers the potential to predict oncological outcomes from pre‐operative imaging, aiding in the identification of ‘high risk’ patients with sinonasal cancer who are at an increased risk of recurrence. This study aims to comprehensively review the current literature on the role of radiomics as a predictor of disease recurrence in sinonasal squamous cell carcinoma.
Methods
A systematic search was conducted in Medline, EMBASE and Web of Science databases. Retrospective and prospective studies examining the use of radiomics to predict post‐operative recurrence in sinonasal cancer that met the inclusion criteria were included. Study quality was assessed using the QUADAS‐2 and Radiomics Quality Score (RQS) tools.
Results
Five studies met the inclusion criteria, encompassing 638 participants. All studies were single‐centre and utilised MRI‐based radiomics in the construction of their models. Radiomic models demonstrated excellent predictive performance. The median AUC, sensitivity and specificity were 0.947, 0.86 and 0.923 in the training set, and 0.914, 0.833 and 0.878 in the validation set. A pooled meta‐analysis estimated the combined AUC across training sets as 0.931 (95% CI, 0.898–0.963) and 0.922 (95% CI, 0.880–0.964) for validation sets.
Conclusion
Our systematic review provides evidence supporting the role of radiomics in predicting post‐operative disease recurrence in sinonasal cancer. Radiomics shows promise in enhancing personalised treatment strategies by improving prognostic accuracy. However, further research is needed to standardise methodologies and validate these findings in larger, multicentre cohorts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Galway University Hospital, Galway, Ireland.
- Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
- Department of Radiology, St. James's Hospital, Dublin, Ireland.
- Trinity St James Cancer Institute, Trinity College Dublin, Dublin, Ireland.
- Department of Radiology and Nuclear Medicine, Erasmus University Medical Center Rotterdam, Rotterdam, the Netherlands.
ORCID-Profile: Hugo C Temperley, Holly Jones, Niall J O'Sullivan
Zitieren
APA
Waters, C., Hall, T., Temperley, H. C., Jones, H., O'Sullivan, N. J., McHugh, A., Tohidinezhad, F., & Subramaniam, T. (2026). Role of Radiomics to Predict Disease Recurrence in Sinonasal Squamous Cell Carcinoma: A Systematic Review and Meta‐Analysis. Clinical Otolaryngology, 51(1), 7-16. https://doi.org/10.1111/coa.70031
Vancouver
Waters C, Hall T, Temperley HC, Jones H, O'Sullivan NJ, McHugh A, et al. Role of Radiomics to Predict Disease Recurrence in Sinonasal Squamous Cell Carcinoma: A Systematic Review and Meta‐Analysis. Clinical Otolaryngology. 2026;51(1):7-16. doi:10.1111/coa.70031
BibTeX
@article{Waters2026,
author = {Waters, Caitlin and Hall, Tamzin and Temperley, Hugo C and Jones, Holly and O'Sullivan, Niall J and McHugh, Alison and Tohidinezhad, Fariba and Subramaniam, Thavakumar},
title = {Role of Radiomics to Predict Disease Recurrence in Sinonasal Squamous Cell Carcinoma: A Systematic Review and Meta‐Analysis},
journal = {Clinical Otolaryngology},
year = {2026},
volume = {51},
number = {1},
pages = {7--16},
doi = {10.1111/coa.70031}
}
EUVIMED